title: Current trends of anticancer immunochemotherapy.
authors.affiliation: Institut Gustave Roussy; Villejuif, France ; Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France ; INSERM, U848; Villejuif, France.
authors.forename: Erika
authors.initials: E
authors.lastname: Vacchelli
authors.forename: Nicole
authors.initials: N
authors.lastname: Prada
authors.forename: Oliver
authors.initials: O
authors.lastname: Kepp
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Galluzzi
keywords: MDSCs; antigenicity; cognate immune effectors; immunogenicity; immunosuppressive networks; innate immune effectors
references.citation: Oncoimmunology. 2012 Dec 1;1(9):1557-1576
references.pmid: 23264902
references.citation: Nat Rev Drug Discov. 2011 Aug 01;10(8):591-600
references.pmid: 21804596
references.citation: Immunity. 2013 Jul 25;39(1):74-88
references.pmid: 23890065
references.citation: Cancer Immunol Immunother. 2009 Mar;58(3):317-24
references.pmid: 18704409
references.citation: Annu Rev Immunol. 2013;31:51-72
references.pmid: 23157435
references.citation: Cancer Res. 2011 Feb 1;71(3):661-5
references.pmid: 21148486
references.citation: Nat Rev Drug Discov. 2012 Feb 03;11(3):215-33
references.pmid: 22301798
references.citation: Oncoimmunology. 2013 Jan 1;2(1):e22789
references.pmid: 23482847
references.citation: Nat Rev Mol Cell Biol. 2012 Dec;13(12):780-8
references.pmid: 23175281
references.citation: J Clin Invest. 2004 Aug;114(3):379-88
references.pmid: 15286804
references.citation: Nat Rev Clin Oncol. 2011 Mar;8(3):151-60
references.pmid: 21364688
references.citation: Oncoimmunology. 2013 Apr 1;2(4):e23803
references.pmid: 23734328
references.citation: Cancer Immunol Immunother. 2012 Dec;61(12):2343-56
references.pmid: 22714286
references.citation: Nat Rev Cancer. 2012 Mar 22;12(4):237-51
references.pmid: 22437869
references.citation: Mol Cancer Ther. 2012 Jan;11(1):3-13
references.pmid: 22234808
references.citation: Oncoimmunology. 2012 Sep 1;1(6):793-797
references.pmid: 23162746
references.citation: Clin Cancer Res. 2005 Sep 15;11(18):6713-21
references.pmid: 16166452
references.citation: Oncoimmunology. 2012 Oct 1;1(7):1038-1047
references.pmid: 23170252
references.citation: Annu Rev Immunol. 2013;31:413-41
references.pmid: 23298206
references.citation: Oncoimmunology. 2012 Mar 1;1(2):214-216
references.pmid: 22720246
references.citation: Oncoimmunology. 2012 Oct 1;1(7):1111-1134
references.pmid: 23170259
references.citation: Oncoimmunology. 2012 Jan 1;1(1):28-37
references.pmid: 22720209